Novel uses for recombinant erythropoietin therapy in unlicensed indications.

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	181-185
Number of pages	5
Journal	The hematology journal : the official journal of the European Haematology Association / EHA
Volume	5(2)
Issue number	2
DOIs	https://doi.org/10.1038/sj.thj.6200350
Publication status	Published - 2004

ASJC Scopus subject areas

@article{c497255bc5c047cf91caf0ba5be87945,

title = "Novel uses for recombinant erythropoietin therapy in unlicensed indications.",

author = "C.A. Macartney and A.A. Adgey and F.G. Jones and Morris, \{T C M\} and Mary McMullin",

year = "2004",

doi = "10.1038/sj.thj.6200350",

language = "English",

volume = "5(2)",

pages = "181--185",

journal = "The hematology journal : the official journal of the European Haematology Association / EHA",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Novel uses for recombinant erythropoietin therapy in unlicensed indications.

AU - Macartney, C.A.

AU - Adgey, A.A.

AU - Jones, F.G.

AU - Morris, T C M

AU - McMullin, Mary

PY - 2004

Y1 - 2004

UR - https://www.scopus.com/pages/publications/1942441697

U2 - 10.1038/sj.thj.6200350

DO - 10.1038/sj.thj.6200350

M3 - Article

C2 - 15048070

VL - 5(2)

SP - 181

EP - 185

JO - The hematology journal : the official journal of the European Haematology Association / EHA

JF - The hematology journal : the official journal of the European Haematology Association / EHA

IS - 2

ER -